Kinentia Biosciences LLC
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersRensselaer, NY
US patents2
SAM.gov UEILMKTA3Y6AUN5
CAGE code4XB93
Incorporated inNY
- contract research
- consulting services
- pharmaceutical
- development
- commercialization
- continental USA
Named on the company’s own website, read JUL 29, 2026
Supplier designations
For Profit OrganizationManufacturer of Goods
Self-certified by the company in its SAM.gov registration
Patents
2 US patents granted in 2014, none of them in the five years to SEP 2025.
Organic fine chemistry 1Pharmaceuticals 1
- 4-fluoro-4-arylpiperdin-1-yl derivatives as mu opioid function moderatorsUS 8,859,777 · granted OCT 14, 2014
- Pyrazole derivatives as ERK inhibitorsUS 8,697,697 · granted APR 15, 2014
Granted to Kinentia Biosciences LLC · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Kinentia Biosciences LLC | Rensselaer | NY | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.